Cargando…

Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing

Detalles Bibliográficos
Autor principal: Seiler, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837304/
https://www.ncbi.nlm.nih.gov/pubmed/27141457
http://dx.doi.org/10.21037/tau.2016.02.01
_version_ 1782427831235510272
author Seiler, Roland
author_facet Seiler, Roland
author_sort Seiler, Roland
collection PubMed
description
format Online
Article
Text
id pubmed-4837304
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-48373042016-05-02 Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing Seiler, Roland Transl Androl Urol Commentary AME Publishing Company 2016-04 /pmc/articles/PMC4837304/ /pubmed/27141457 http://dx.doi.org/10.21037/tau.2016.02.01 Text en 2016 Translational Andrology and Urology. All rights reserved.
spellingShingle Commentary
Seiler, Roland
Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title_full Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title_fullStr Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title_full_unstemmed Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title_short Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
title_sort predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic dna sequencing
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837304/
https://www.ncbi.nlm.nih.gov/pubmed/27141457
http://dx.doi.org/10.21037/tau.2016.02.01
work_keys_str_mv AT seilerroland predictingresponsetoneoadjuvantchemotherapyinbladdercancercontroversiesremainwithgenomicdnasequencing